Partner: Paulina Wigner

University of Lodz (PL)

Recent publications
1.Sliwinska A., Sitarek P., Toma M., Czarny P., Synowiec E., Krupa R., Wigner P., Bialek K., Kwiatkowski D., Korycinska A., Majsterek I., Szemraj J., Galecki P., Sliwinski T., Decreased expression level of BER genes in Alzheimer's disease patients is not derivative of their DNA methylation status, PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, ISSN: 0278-5846, DOI: 10.1016/j.pnpbp.2017.07.010, Vol.79, pp.311-316, 2017
Abstract:

Background: Neurodegeneration in Alzheimer's disease can be caused by accumulation of oxidative DNA damage resulting from altered expression of genes involved in the base excision repair system (BER). Promoter methylation can affect the profile of BER genes expression. Decreased expression of BER genes was observed in the brains of AD patients.
Aim of the study: The aim of our study was to compare the expression and methylation profiles of six genes coding for proteins involved in BER, namely: hOGG1, APE1, MUTYH, NEIL1, PARP1 and XRCC1, in the peripheral blood cells of AD patients and healthy volunteers.
Methods: The study consisted of 100 persons diagnosed with Alzheimer's disease according to DSM-IV criteria, and 110 healthy volunteers. DNA and total RNA were isolated from venous blood cells. Promoter methylation profiles were obtained by High Resolution Melting (HRM) analysis of bisulfide converted DNA samples. Real-time PCR with TaqMan probes was employed for gene expression analysis.
Results: APE1, hOGG1, MUTYH, PARP1 and NEIL1 were significantly (p < 0.001) down-regulated in the lymphocytes of AD patients, as compared to healthy volunteers. Expression of XRCC1 didn't differ significantly between both groups. We did not find any differences in the methylation pattern of any of the investigated BER genes.
Conclusions: The methylation status of promoters is not associated with downregulation of BER genes. Our results show that downregulation of BER genes detected in peripheral blood samples could reflect the changes occurring in the brain of patients with AD, and may be a useful biomarker of this disease.

Keywords:

Alzheimer's disease, DNA base excision repair genes, Gene expression, Promoter methylation

Affiliations:
Sliwinska A.-Medical University of Lodz (PL)
Sitarek P.-Medical University of Lodz (PL)
Toma M.-University of Lodz (PL)
Czarny P.-Medical University of Lodz (PL)
Synowiec E.-University of Lodz (PL)
Krupa R.-University of Lodz (PL)
Wigner P.-University of Lodz (PL)
Bialek K.-University of Lodz (PL)
Kwiatkowski D.-other affiliation
Korycinska A.-University of Lodz (PL)
Majsterek I.-Medical University of Lodz (PL)
Szemraj J.-Medical University of Lodz (PL)
Galecki P.-Medical University of Lodz (PL)
Sliwinski T.-University of Lodz (PL)
2.Sliwinska A., Kwiatkowski D., Czarny P., Toma M., Wigner P., Drzewoski J., Fabianowska-Majewska K., Szemraj J., Maes M., Gałecki P., Śliwiński T., The levels of 7,8-dihydrodeoxyguanosine (8-oxoG) and 8-oxoguanine DNA glycosylase 1 (OGG1) - A potential diagnostic biomarkers of Alzheimer's disease, JOURNAL OF THE NEUROLOGICAL SCIENCES, ISSN: 0022-510X, DOI: 10.1016/j.jns.2016.07.008, Vol.368, pp.155-159, 2016
Abstract:

Evidence indicates that oxidative stress contributes to neuronal cell death in Alzheimer's disease (AD). Increased oxidative DNA damage I, as measured with 8-oxoguanine (8-oxoG), and reduced capacity of proteins responsible for removing of DNA damage, including 8-oxoguanine DNA glycosylase 1 (OGG1), were detected in brains of AD patients. In the present study we assessed peripheral blood biomarkers of oxidative DNA damage, i.e. 8-oxoG and OGG1, in AD diagnosis, by comparing their levels between the patients and the controls. Our study was performed on DNA and serum isolated from peripheral blood taken from 100 AD patients and 110 controls. For 8-oxoG ELISA was employed. The OGG1 level was determined using ELISA and Western blot technique. Levels of 8-oxoG were significantly higher in DNA of AD patients. Both ELISA and Western blot showed decreased levels of OGG1 in serum of AD patients. Our results show that oxidative DNA damage biomarkers detected in peripheral tissue could reflect the changes occurring in the brain of patients with AD. These results also suggest that peripheral blood samples may be useful to measure oxidative stress biomarkers in AD.

Keywords:

Alzheimer's disease, Oxidative stress, Oxidative DNA damage, 7 8-dihydrodeoxyguanosine (8-oxoG), DNA base excision repair, 8-oxoguanine DNA glycosylase 1 (OGG1)

Affiliations:
Sliwinska A.-Medical University of Lodz (PL)
Kwiatkowski D.-other affiliation
Czarny P.-Medical University of Lodz (PL)
Toma M.-University of Lodz (PL)
Wigner P.-University of Lodz (PL)
Drzewoski J.-Medical University of Lodz (PL)
Fabianowska-Majewska K.-Medical University of Lodz (PL)
Szemraj J.-Medical University of Lodz (PL)
Maes M.-Deakin University (AU)
Gałecki P.-Medical University of Lodz (PL)
Śliwiński T.-University of Lodz (PL)